These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7915368)

  • 1. Efficacy of low-density-lipoprotein lowering with statins.
    Leufkens HG; Herings RM; Urquhart J
    Lancet; 1994 Sep; 344(8923):683-4. PubMed ID: 7915368
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of low-density-lipoprotein lowering with statins.
    Seidel D; Cremer P
    Lancet; 1994 Sep; 344(8923):683. PubMed ID: 7915367
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of low-density-lipoprotein lowering with statins.
    Rosenson RS; Stein JH
    Lancet; 1994 Sep; 344(8923):683. PubMed ID: 7915366
    [No Abstract]   [Full Text] [Related]  

  • 4. Defined daily doses in relation to hypolipidaemic efficacy of lovastatin, pravastatin, and simvastatin.
    Illingworth DR; Erkelens DW; Keller U; Thompson GR; Tikkanen MJ
    Lancet; 1994 Jun; 343(8912):1554-5. PubMed ID: 7911877
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of low-density-lipoprotein lowering with statins.
    Marshall S; Meredith PA; Elliott HL
    Lancet; 1994 Sep; 344(8923):684. PubMed ID: 7915369
    [No Abstract]   [Full Text] [Related]  

  • 6. Reducing expenditures for statin-type lipid-lowering agents.
    Am J Health Syst Pharm; 1998 May; 55(10):995-6, 999. PubMed ID: 9606450
    [No Abstract]   [Full Text] [Related]  

  • 7. Lipid-lowering with statins and fibrinolytic parameters.
    Jovin IS; Heidinger K; Taborski U; Muller-Berghaus G
    Eur Heart J; 1997 Sep; 18(9):1516. PubMed ID: 9458463
    [No Abstract]   [Full Text] [Related]  

  • 8. [Efficacy and safety of simvastatin in the treatment of hyperlipidemia in uremic patients undergoing hemodialysis treatment].
    Fiorini F; Patrone E; Ardu F; Castelluccio A
    Minerva Urol Nefrol; 1992; 44(2):165-8. PubMed ID: 1411867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of high doses of simvastatin as monotherapy in mixed hyperlipidemia.
    Miller M; Dolinar C; Cromwell W; Otvos JD
    Am J Cardiol; 2001 Jan; 87(2):232-4, A9. PubMed ID: 11152850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of simvastatin in hyperlipidemic renal transplant patients receiving cyclosporine.
    Rehman MA; al-Sulaiman MH; Mousa DH; al-Hawas FA; Abdalla AH; Rassoul Z; al-Khader AA
    Transplantation; 1995 Aug; 60(4):397-9. PubMed ID: 7652773
    [No Abstract]   [Full Text] [Related]  

  • 11. Consensus statement: Role of therapy with "statins" in patients with hypertriglyceridemia.
    Grundy SM
    Am J Cardiol; 1998 Feb; 81(4A):1B-6B. PubMed ID: 9526806
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of hydroxymethylglutaryl coenzyme A reductase inhibitors in patients with post-transplantation hyperlipemia].
    Martínez-Castelao A
    Med Clin (Barc); 1995 Nov; 105(18):719. PubMed ID: 8538262
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cardiovascular pharmacology (VIII). The role of HMG CoA reductase inhibitors in the current treatment of hyperlipidemias].
    Carmena R
    Rev Esp Cardiol; 1995 Jan; 48(1):59-65. PubMed ID: 7878284
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of simvastatin, an HMG-CoA reductase inhibitor, on plasma lipids and steroid hormones.
    Ide H; Fujiya S; Aanuma Y; Agishi Y
    Clin Ther; 1990; 12(5):410-20. PubMed ID: 2268863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of ezetimibe/simvastatin, rosuvastatin, and atorvastatin in uncontrolled hyperlipidemia patients.
    Furman A; Meier JL; Malmstrom RA; Lopez JR; Schaefer S
    Am J Manag Care; 2011; 17(8):538-44. PubMed ID: 21851141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosing and administration schedule of HMG CoA reductase inhibitors.
    Sweany AE
    Heart Dis Stroke; 1993; 2(3):263. PubMed ID: 8179691
    [No Abstract]   [Full Text] [Related]  

  • 17. Cost-benefit analysis of lipid lowering therapy.
    Davie AP; McMurray JJ
    Eur Heart J; 1996 Jul; 17(7):974-5. PubMed ID: 8809507
    [No Abstract]   [Full Text] [Related]  

  • 18. Simvastatin therapy for hypercholesterolaemia in patients with coronary heart disease.
    French JK; White HD; Greaves SC
    N Z Med J; 1990 Feb; 103(883):41-3. PubMed ID: 2304688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Separate and joint effects of marine oil and simvastatin in patients with combined hyperlipidemia.
    Davidson MH; Macariola-Coad JR; McDonald AM; Maki KC; Hall HA
    Am J Cardiol; 1997 Sep; 80(6):797-8. PubMed ID: 9315596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-benefit analysis of lipid lowering therapy.
    Jönsson B; Johannesson M
    Eur Heart J; 1997 Jan; 18(1):165-6. PubMed ID: 9049529
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.